Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin

1985 ◽  
Vol 19 (3) ◽  
Author(s):  
Nanne Bloksma ◽  
FransM.A. Hofhuis ◽  
JanM.N. Willers
1988 ◽  
Vol 53 (11) ◽  
pp. 2897-2906 ◽  
Author(s):  
Jan Ježek ◽  
Milan Zaoral ◽  
Miloš Buděšínský ◽  
Jiří Günther ◽  
Jiří Rotta

In the search for immunoadjuvant active compounds without pyrogenic activity we prepared N-Ac-norMur-L-Abu-D-Gln-O-Bu (V), N-Ac-Mur-L-Abu-D-Gln-O-Bu (VII) and their respective α-benzylglycosides VI and VIII. All the prepared compounds are nonpyrogenic. In the delayed hypersensitivity test, compound V is inactive, VI is comparable to MDP, VII is more and VIII is less active than MDP.


2019 ◽  
Vol 15 ◽  
pp. 1805-1814 ◽  
Author(s):  
Rosana Ribić ◽  
Ranko Stojković ◽  
Lidija Milković ◽  
Mariastefania Antica ◽  
Marko Cigler ◽  
...  

Muramyl dipeptide is the minimal structure of peptidoglycan with adjuvant properties. Replacement of the N-acetylmuramyl moiety and increase of lipophilicity are important approaches in the preparation of muramyl dipeptide analogues with improved pharmacological properties. Mannose receptors present on immunocompetent cells are pattern-recognition receptors and by mannose ligands binding they affect the immune system. Here we present the design, synthesis and biological evaluation of novel mannosylated desmuramyl peptide derivatives. Mannose was coupled to dipeptides containing a lipophilic adamantane on N- or C-terminus through a glycolyl or hydroxyisobutyryl linker. Adjuvant activities of synthesized compounds were investigated in the mouse model using ovalbumin as an antigen. Their activities were compared to the previously described mannosylated adamantane-containing desmuramyl peptide and peptidoglycan monomer. Tested compounds exhibited adjuvant activity and the strongest enhancement of IgG production was stimulated by compound 21 (Man-OCH2-ᴅ-(1-Ad)Gly-ʟ-Ala-ᴅ-isoGln).


Biopolymers ◽  
1993 ◽  
Vol 33 (7) ◽  
pp. 1149-1157 ◽  
Author(s):  
P. Pristov?ek ◽  
J. Kidri? ◽  
J. Mavri ◽  
D. Had?I

2019 ◽  
Vol 92 (2) ◽  
pp. 153-161 ◽  
Author(s):  
Rosana Ribić ◽  
Marija Paurević ◽  
Srđanka Tomić

Immune adjuvants are added to vaccines in order to enhance the immune response to an antigen. Muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine, is the smallest structural unit of peptidoglycans showing the immunostimulating activity. Muramyl dipeptide analogues without the hydrophilic N-acetylmuramyl moiety are called desmuramyl peptides. Here, we provide review of desmuramyl peptides which were synthesized in order to improve the pharmacological properties of parent muramyl dipeptide, including our results regarding adamantane containing derivatives. Approach for future design of novel immunostimulators based on multiple pathogen recognition receptor activation was also considered.


Vaccine ◽  
1988 ◽  
Vol 6 (3) ◽  
pp. 238-244 ◽  
Author(s):  
Ikuo Salki ◽  
Shinji Saito ◽  
Chiharu Fujita ◽  
Hideharu Ishida ◽  
Joji Iida ◽  
...  

2019 ◽  
Author(s):  
Rosana Ribić ◽  
Ranko Stojković ◽  
Lidija Milković ◽  
Mariastefania Antica ◽  
Marko Cigler ◽  
...  

Muramyl dipeptide is the minimal structure of peptidoglycan with adjuvant properties. Replacement of the N-acetylmuramyl moiety and increase of lipophilicity are important approaches in the preparation of muramyl dipeptide analogues with improved pharmacological properties. Mannose receptors present on immunocompetent cells are pattern-recognition receptors and by mannose ligands binding they affect the immune system. Here we present design, synthesis and biological evaluation of novel mannosylated desmuramyl peptide derivatives. Mannose was coupled to dipeptide containing lipophilic adamantane on N- or C-terminus through glycolyl or hydroxyisobutyryl linker. Adjuvant activities of synthesized compounds were investigated in the mouse model using ovalbumin as an antigen. Their activities were compared to the previously described mannosylated adamantane-containing desmuramyl peptide and peptidoglycan monomer. Tested compounds exhibited adjuvant activity and the strongest enhancement of IgG production was stimulated by the compound 21 (Man-OCH2-D-(1-Ad)Gly-L-Ala-D-isoGln).


2018 ◽  
Vol 8 (8) ◽  
pp. 1048-1072
Author(s):  
Abdou Saad El-Tabl ◽  
Moshira Mohamed Abd-El Wahed ◽  
Seham Abd-El Rafea El-Saied

Sign in / Sign up

Export Citation Format

Share Document